liquid biopsy

The customized solution enables the team to make informed variant interpretations and treatment recommendations

Researchers have found that a test to detect circulating tumor DNA can predict lung cancer outcome

Screening successes, emerging technologies, precision treatments, and other steps forward from the AACR Cancer Progress Report 2024

The blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers could help screen women for early signs of ovarian cancer

Trailblazing labs are among the first to adopt new tests and treatments for longstanding challenges

An analytical tool called EV fingerprinting could soon replace traditional invasive biopsies for certain diseases

The liquid biopsy market is expected to increase by approximately 20 percent between 2022 and 2032

When combined with CA 19-9, the novel biopsy accurately detected 97 percent of stage 1–2 pancreatic cancers

A blood test will be better than nothing, but may lead to more CRC cases and deaths than established screening tests

Liquid biopsy helps screen for ctDNA, which is linked to how patients respond to immuno- and chemo-therapy ​